NCT06449495

Brief Summary

Balance and coordination disorders limit the achievement of autonomy in movement and activities of daily living in pediatric population. There are several systems that can be used to treat balance and coordination disorders and those that use virtual reality, such as NIRVANA, are becoming increasingly popular. The primary objective of this post-market clinical investigation is to evaluate the efficacy of the semi-immersive virtual reality platform NIRVANA (BTS Bioengineering), in accordance with the protocol defined at IRCCS Medea in Bosisio Parini, in children with balance and coordination disorders on both motor function and cognitive processes that are indirectly stimulated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Sep 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Sep 2012Dec 2027

Study Start

First participant enrolled

September 1, 2012

Completed
11.1 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2023

Completed
8 months until next milestone

First Posted

Study publicly available on registry

June 10, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 9, 2024

Status Verified

July 1, 2024

Enrollment Period

15.3 years

First QC Date

October 17, 2023

Last Update Submit

July 8, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Stabilometry with force platforms

    Evaluation of static balance

    T0(pre-training),T1 (after 4 weeks of training)

  • Gross Motor Function Measure-88 (GMFM-88)

    Evaluation of the motricity

    T0(pre-training),T1 (after 4 weeks of training)

  • Pediatric Berg Balance Scale (PBBS)

    Functional balance

    T0(pre-training),T1 (after 4 weeks of training)

Secondary Outcomes (1)

  • Continuous Performance Test (CPT or KCPT)

    T0(pre-training),T1 (after 4 weeks of training)

Study Arms (1)

coordination and balance disorders

EXPERIMENTAL

Subjects will undergo treatment with NIRVANA lasting 45 minutes for 5 sessions per week for 4 weeks combined with equal dose of task-oriented physiotherapy treatment.

Device: NIRVANA

Interventions

NIRVANADEVICE

NIRVANA is a medical device using semi-immersive virtual reality for motor and cognitive neuro-rehabilitation. NIRVANA creates a "sensory room" where the patient can have an immersive and stimulating experience by interacting directly with different realistic scenarios. The system creates different scenarios on the wall or floor, and the patient interacts with the stimuli provided. A motion-analysis device detects the patient's behavior and based on the projected environment provides highly stimulating and rehabilitative audiovisual feedback with full whole-body immersion. The system is preconfigured with a series of exercises, which can be customized based on different types of patients, intervening on the level of difficulty, speed of execution and sensitive area of the projection.

coordination and balance disorders

Eligibility Criteria

Age4 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • balance or coordination disorders of different etiology: tumor, post-traumatic, neurodegenerative, syndromic, congenital, or associated with neurodevelopmental delay. - - - age between 4 and 17 years
  • independent ambulation
  • ability to understand simple verbal instructions.

You may not qualify if:

  • adult
  • wheelchair-bound
  • major cognitive and behavioural problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Irccs Eugenio Medea

Bosisio Parini, Lecco, 23842, Italy

RECRUITING

Irccs Eugenio Medea

Conegliano, Treviso, 31015, Italy

RECRUITING

Associazione "La Nostra Famiglia" - Polo Ospedaliero di Neuroriabilitazione, Piazza Di Summa presso ex Complesso Ospedaliero Regionale "A. Di Summa"

Brindisi, 72100, Italy

RECRUITING

Central Study Contacts

ELEONORA DIELLA, PHYSIOTHERAPIST

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2023

First Posted

June 10, 2024

Study Start

September 1, 2012

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 9, 2024

Record last verified: 2024-07

Locations